Company Snapshot
ADARx Pharmaceuticals, Inc. investment report
Start with ADRX at a glance, then work through valuation, price history, fundamentals, management, competitors, and analyst expectations.
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.53B
- Beta
- 0.00
Volume 0.70M
Average 1.06M
Intrinsic Value
ADRX Intrinsic Value
Start with the valuation result. Compare the current market price with the system DCF estimate, then use the supporting sections below to decide whether the assumptions are reasonable.
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$13.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Monitor ADRX
Get notified when the price moves into your range
Use alerts to turn the valuation into an action plan instead of checking the stock manually.
Price alerts
Get notified when ADRX drops below your target
Current price baseline
$13.82
Current price $13.82
Sign in to activate price alerts.
Price History
How has ADRX traded over time?
Review how the market has priced ADARx Pharmaceuticals, Inc. over time, alongside earnings and dividend events, before deciding whether today’s price is unusual.
Price history
Dividend-adjusted closing price
Period change
-28.58%
Period high
$20.64
Period low
$13.23
Latest
$13.82
Investment Notes
Capture the investment case
Write down the key idea, risks, and what would change your mind before testing the thesis against the fundamentals below.
My notes
Journal entries for ADRX
Sign in to keep notes
Keep your research and decisions in your personal journal.
Fundamental Analysis
Test company quality against your thesis
Work through profitability, revenue mix, financial position, cash generation, compounding numbers, and growth to see whether the business supports the investment case.
Earnings Quality
Follow revenue through to net income
Use the waterfall to see which costs, margins, and operating lines explain how much of each sales dollar becomes profit.
ADRX Earnings Waterfall · TTM
NASDAQ:ADRX · Revenue to Net Income
No earnings data available.
Revenue Mix
See which products and regions drive the business
Growth is easier to trust when you know where it comes from. Check whether one segment or region carries the company and how the mix is shifting.
Revenue by segment
Where ADRX earns its revenue, as reported in company filings
This company does not report revenue segments.
Financial Position
Check what supports the company underneath the income statement
The balance sheet shows liquidity, debt, asset mix, and book value quality before you rely on earnings or growth assumptions.
Balance Sheet
Assets, liabilities & equity
No balance sheet data available.
Cash Generation
Test whether profit turns into cash
Free cash flow connects accounting earnings to owner earnings, showing how much cash remains after reinvestment needs.
Free Cash Flow
Net Income to FCF bridge
No cash flow data available.
Quality Snapshot
Check the numbers that compound value
Check whether earnings, revenue, equity, cash, and returns on capital are moving in the same direction as your written thesis.
Growth Profile
Compare historical growth with forward expectations
Strong past growth matters more when analysts still expect the business to expand without relying on one temporary driver.
Growth Analysis
Historical CAGR & forward analyst estimates
Management
Judge how ADARx Pharmaceuticals, Inc. allocates capital
Review returns on capital, owner payouts, dividend durability, insider activity, and the leadership responsible for these decisions.
Capital Efficiency
Returns on equity, invested capital, and assets help separate durable operators from businesses that only grow by adding more capital.
Return Metrics
ROE, ROIC & ROA over time
No return metrics data available.
Dividend Record
A dividend is more useful when growth, payout ratio, and free cash flow support the current yield.
Dividends
Dividend history, growth & yield
Yield
—
Annual Div/Share
$0.00
Payout Ratio
—
Frequency
—
Shareholder Yield
—
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is not available.
Owner Returns
Dividends, buybacks, and debt paydown show whether excess cash is being reinvested, returned, or used to strengthen the balance sheet.
Shareholder Returns
Dividend, buyback & debt paydown yields
No shareholder return data available.
Insider Activity
Insider transactions add context to ownership incentives and can reveal when leadership behavior diverges from the public investment case.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Leadership
Leadership context helps you judge who is responsible for strategy, capital allocation, and execution.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Li Zhen | Co-Founder, President, CEO & Director | USD 875.41K | 65 | — | — |
Zhen Li | Co-Founder, President, CEO & Director | USD 875.41K | 64 | — | — |
Robert A. MacLeod | Chief Scientific Officer | USD 640.51K | 59 | — | — |
Ryan Fisk | CFO & Chief Business Officer | — | 44 | — | — |
Christopher Claeboe | Senior Vice President of Operations | — | — | — | — |
Rui Zhu | Chief Technology Officer | — | 43 | — | — |
Jiang Bian | VP & Head of Legal | — | — | — | — |
Robert Ackles | Chief People Officer | — | 61 | — | — |
Compensation is shown in the reported currency; data updated Nov 14, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.
Alternatives to ADRX
Compare ADARx Pharmaceuticals, Inc. with similar companies
A stock can look attractive in isolation and still be less compelling than a peer. Check competitors before committing to the thesis.
Competitors
Peer companies in the same sector
Analysts
What Wall Street expects from ADRX
Compare consensus price targets and ratings with your own valuation to understand how much optimism the market is already pricing in.
Analyst Targets
See where analysts expect ADRX to trade next
Compare the latest consensus target range with the current share price to understand how much upside or downside Wall Street is pricing in.
Wall Street price targets
1-year price history with analyst consensus target
Unlock analyst target range
Sign in free to see low, average, high targets and implied upside for ADRX.
Analyst Ratings
How analysts rate ADRX today
See the buy, hold, and sell split behind the consensus and whether recent rating changes lean toward upgrades or downgrades.
Analyst ratings
Buy, hold, and sell recommendations and recent rating changes
Unlock analyst ratings
Sign in free to see the buy/hold/sell breakdown and recent rating changes for ADRX.
Company Overview
Understand how ADARx Pharmaceuticals, Inc. makes money
Ground the financial evidence in the company profile, business description, and key facts.
Key Information
Stock Analysis
Turn the ADRX report into your next decision
Record your conclusion, evidence, and concerns in a structured analysis workspace.
Investment analysis
Turn ADRX research into a decision
Work through Know the Business, Test the Moat, Management, and Intrinsic Value in one private, repeatable checklist.
Sign in on the next page to save a private analysis.
Start analysisFAQ
Common questions about ADRX
Resolve the remaining questions before moving into the detailed workspaces.
Explore
Continue your research
Open the detailed valuation, financial, health, and management workspaces.
Continue the stock analysis
Jump to another research area for this company.